Actively Recruiting
Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
Led by Sheba Medical Center · Updated on 2026-04-09
120
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
Sponsors
S
Sheba Medical Center
Lead Sponsor
T
Tel-Aviv Sourasky Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.
CONDITIONS
Official Title
Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of type 1 diabetes
- Diabetes duration of 6 months or more
- Routine attendance at clinic visits
- Starting use of the 780G system
You will not qualify if you...
- Children under the age of 1 year
- Children not using the 780G system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sheba Medical Center
Ramat Gan, Please Select, Israel, 5265601
Actively Recruiting
Research Team
N
Noah Gruber, MD
CONTACT
E
Elinor Mauda, BSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here